Dale Heuer, MD
Professor Emeritus
Biography
Dr. Heuer moved to the Bascom Palmer Eye Institute in Miami, Florida for a National Research Service Award funded fellowship in glaucoma from 1982-1984. During his fellowship he achieved American Board of Ophthalmology at the University of Florida in Gainesville.
He moved to the Doheny Eye Institute at the University of Southern California as assistant professor of ophthalmology in 1986. In 1996 he was appointed professor. The following year, Dr. Heuer returned to 91ɫƵ as professor and chair of the department of ophthalmology & visual sciences. He served in this role for 21 years before retiring.
Dr. Heuer’s professional activities include having served as the representative to the Council for Graduate Medical Education Residency Review Committee of Ophthalmology of the American Academy of Ophthalmology and a voting member of the Food and Drug Administration Ophthalmic Devices Panel. He currently serves on the American Board of Directors and the Association of University Professors of Ophthalmology, Fellowship Compliance Committee Board of Managers. He has served as a peer manuscript reviewer for the American Journal of Ophthalmology (AJO).
Dr. Heuer and his wife Jeanine have four children. In his retirement, he spends time at his residences in California and Idaho.
Honors and Awards
American Academy of Ophthalmology Lifetime Achievement Award (2012)
Academic Champion Award in Government Affairs (2001)
Secretariat Awards (two awards – one from the Secretary for Annual Meeting and one from the Chief Medical Editor, EyeNet 2007)
Achievement awards were given from the following professional journals:
Archives of Ophthalmology (AO)
Investigative Ophthalmology & Visual Science (IOVS)
The Journal of Glaucoma
The Journal of Ophthalmology
The Survey of Ophthalmology
Research Interests
Dr. Heuer was a clinical center principal investigator for the National Eye Institute funded Fluorouracil Filtering Surgery and Collaborative Glaucoma Treatment study. He served as one of three Vice Chairs for the NEI-funded Ocular Hypertension Treatment study.